HYPIC Hypnosis for Procedural Pain in the Intensive Care Unit

Sponsor
Rennes University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04129333
Collaborator
(none)
80
2
2
34
40
1.2

Study Details

Study Description

Brief Summary

Procedural pain in resuscitation is common in the conscious patient. However, analgesia and sedation may be impossible because of the acute pathology leading to resuscitation, comorbidities or the urgency of the invasive procedure. In addition, the use of analgesics and sedatives is responsible for adverse effects. In this context, hypnosis appears to be an additional analgesic tool that would reduce the consumption of analgesics and sedatives and thus reduce their side effects.

Condition or Disease Intervention/Treatment Phase
  • Other: Hypnosis
  • Other: No hypnosis
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Multicenter prospective national, controlled, randomized, superiority study, open-label with blind evaluation, on 2 parallel groupsMulticenter prospective national, controlled, randomized, superiority study, open-label with blind evaluation, on 2 parallel groups
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
HYPIC Hypnosis for Procedural Pain in the Intensive Care Unit
Actual Study Start Date :
Dec 30, 2019
Anticipated Primary Completion Date :
Jul 30, 2022
Anticipated Study Completion Date :
Oct 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Hypnosis group

A hypnosis group with standard care during the invasive procedure according to the usual practice of the care team and setting up a hypnotic accompaniment by an nurse trained beforehand and dedicated throughout the gesture. The hypnosis session will end at the same time as the invasive procedure.

Other: Hypnosis
The hypnosis session : Creation of the therapist-patient link Choice of a theme and the preferred sensory channel by the patient Collection of the theme chosen by the patient Orientation in the here and now. Induction Realization of the gesture and hypnosis At the end of the procedure, reassociation of the patient in the here and now

Placebo Comparator: Control group

A control group with standard care during the invasive procedure according to the usual practice of the care team.

Other: No hypnosis
No hypnosis

Outcome Measures

Primary Outcome Measures

  1. Pain assessment [Immediately after the end of the invasive procedure (Hour 0)]

    Oral assessment scale (0 : no pain - 10 : maximal pain)

Secondary Outcome Measures

  1. Pain assessment [The first hour after the end of the procedure (Hour 1)]

    Oral assessment scale (0 : no pain - 10 : maximal pain)

  2. Morphine equivalent dose [Immediately after the end of the invasive procedure (H0) and the first hour after the end of the procedure (H1)]

    Cumulative use of morphine-morphine analgesics in morphine equivalent during the procedure and the first hour after the end of the procedure (H1)

  3. Sedatives dose [Immediately after the end of the invasive procedure (Hour 0) and the first hour after the end of the procedure (Hour 1)]

    Cumulative use of sedatives during the procedure and the first hour after the end of the procedure (H1)

  4. Local Anesthesia dose [Immediately after the end of the invasive procedure (Hour 0)]

    Consumption of local anesthesia during the invasive procedure

  5. Comfort scale [Immediately after the end of the invasive procedure (H0) and the first hour after the end of the procedure (H1)]

    Comfort measured by the numerical comfort scale (0 no comfort - 10 most comfortable situation imaginable)

  6. Anxiety [Immediately after the end of the invasive procedure (Hour 0) and the first hour after the end of the procedure (Hour 1)]

    Patient anxiety measured by the numerical anxiety scale (0 no anxiety - 10 greatest anxiety imaginable) .

  7. Duration [Immediately after the end of the invasive procedure (Hour 0)]

    Duration of the invasive procedure including the period of hypnosis

  8. Number of attempts and failures of the procedure [The first hour after the end of the procedure (Hour 1)]

    Number of attempts and failures of the procedure

  9. Adverse events [The first hour after the end of the procedure (Hour 1)]

    Number of adverse events occurring during the procedure (hematoma, failure to pose, ...)

  10. Nurse stress [Immediately after the end of the invasive procedure (Hour 0)]

    Stress of the nurse in charge of the patient quantified by a numerical scale of evaluation (0 no stress - 10 greatest stress imaginable)

  11. Length of stay in intensive care unit [Day 28]

    Length of stay in intensive care unit, measured until D28

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Major patient admitted to intensive care

  • Glasgow score = 15

  • Necessity during the stay of making an invasive gesture among:

  • Thoracic drainage

  • Placement of a central venous catheter or a Swan-Ganz catheter

  • Establishment of a dialysis catheter

  • Introduction of an invasive arterial catheter

  • Patient giving free, informed and written consent

  • Patient affiliated to a social security scheme

Non inclusion Criteria:
  • Procedure to be carried out in extreme urgency

  • Confusional state making hypnosis impossible, evaluated by CAM-ICU (Confusion Assessment Method for the Intensive Care Unit)

  • Decompensated psychiatric illness

  • Patient sedated or intravenous analgesia continued at the time of the procedure

  • Patient intubated

  • Patient with a contraindication to sedation or analgesia at the time of the procedure

  • Patient receiving topical anesthesia before the start of the procedure

  • Major person subject to legal protection (court bail, curator, guardianship) or deprived of liberty

  • Patient already included in the study during the completion of a previous invasive procedure

  • Patient participating in a research involving an interventional human person (category

  1. on an analgesic / sedative drug

Contacts and Locations

Locations

Site City State Country Postal Code
1 Saint-Brieuc Hospital Saint-Brieuc Bretagne France 22000
2 Rennes University Hospital Rennes France 35033

Sponsors and Collaborators

  • Rennes University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rennes University Hospital
ClinicalTrials.gov Identifier:
NCT04129333
Other Study ID Numbers:
  • 35RC18_8853_HYPIC
  • 2019-A01775-52
First Posted:
Oct 16, 2019
Last Update Posted:
Jun 1, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 1, 2021